# Compass Therapeutics (CMPX) — News

CMPX · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/cmpx/news

## Recent headlines

- [EU clears acquisition of BTZ by CM and Bunge](https://www.ainvest.com/news/eu-clears-acquisition-btz-cm-bunge-2610) — AInvest Wire, Oct 13, 2026
- [Compass Therapeutics - To further engage with FDA on BLA submission for Tovecimig](https://www.ainvest.com/news/compass-therapeutics-engage-fda-bla-submission-tovecimig-2609) — AInvest Wire, Sep 22, 2026
- [Compass Therapeutics - FDA recommends survival benefit trial before BLA submission for Tovecimig](https://www.ainvest.com/news/compass-therapeutics-fda-recommends-survival-benefit-trial-bla-submission-tovecimig-2609) — AInvest Wire, Sep 22, 2026
- [Compass Therapeutics provides regulatory update on Tovecimig in biliary tract cancer following FDA feedback](https://www.ainvest.com/news/compass-therapeutics-regulatory-update-tovecimig-biliary-tract-cancer-fda-feedback-2609) — AInvest Wire, Sep 22, 2026
- [Compass Therapeutics: $180 mln in cash and marketable securities at end of Q2 2026, which is expected to fund operations into 2028](https://www.ainvest.com/news/compass-therapeutics-180-mln-cash-marketable-securities-q2-2026-expected-fund-operations-2028-2608) — AInvest Wire, Aug 6, 2026

---

Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).